Domestic Chinese Biopharmaceutical Companies -





Chinese Pharmaceutical Market ResearchQ2, 2011  

Whether your organization (or department) views domestic Chinese pharmaceutical companies as a competitor, complementor, or as a catalyst, they are becoming an increasing force in the global healthcare industry. While it is not easy to get summarized company-specific information on domestic Chinese pharmaceutical companies, ISR has done the legwork for you.  

In this report we profile 18 of the largest and fastest growing domestic Chinese pharmaceutical companies. We profile their corporate structure, current products, therapeutic areas of focus, R&D efforts, and financial performance. We think you'll find this report to be a superior source of information on some of China's largest and fastest growing pharmaceutical companies.  

This report contains over 200 pages of information and analysis. The companies profiled in this report accounted for nearly $15 billion USD in revenue in 2010 and over $1.2 billion USD in net income.  

Companies Profiled:  

  • Harbin Pharmaceutical Group 
  • Shineway 
  • Beijing Tongrentang 
  • Simcere Pharmaceutical Group 
  • Qilu Pharmaceutical Company 
  • Beijing Double-crane Pharmaceutical Company 
  • Shanghai Fosun Pharmaceutical Group 
  • Sinovac Biotech 
  • 3SBio 
  • Shanghai Pharmaceutical Group 
  • North China Pharmaceutical Group 
  • Yangtze River Pharmaceutical Group 
  • China Resources Sanjiu Medical & Pharmaceutical Company 
  • Guangzhou Pharmaceutical Holdings 
  • China Buchang Pharmaceutical Group 
  • Shandong Xinhua Pharmaceutical Company 
  • Zhejiang Medicine Company 
  • American Oriental Bioengineering  

Copyright and Usage Guidelines11
Methodology and Definitions12
Introduction13
Executive Summary15
Overview of companies profiled16
2010 Revenue and Net income summary20
2007-2010 Growth rates: revenue and net income21
Harbin Pharmaceutical Group Co., Ltd24
Corporate Background24
Background/History24
Corporate Structure24
Products and Pipeline25
Therapeutic Focus25
Product segments25
HPGC top products by segment25
HPGC trademarks by segment26
Financials27
Shineway30
Corporate Background30
Background History30
Corporate Structure30
Important Press Releases31
Products and Pipelines32
Therapeutic Focus32
Products by segment32
Brand/ Trademark35
Pipeline and R&D35
Financials36
Growth strategies44
Beijing Tongrentang Co., Ltd.45
Corporate Background45
Background/History45
Products and Pipelines45
Therapeutic Focus45
Products45
R&D46
Brand47
Financials48
SimcerePharmaceutical Group51
Corporate Background51
Background/History51
Press Releases53
Products and Pipeline58
Therapeutic Focus58
R&D approach58
Products by Therapeutic Area59
Brand60
Pipeline by TA and Phase60
Financials62
Growth strategies68
QiluPharmaceutical Co., Ltd.69
Corporate Background69
Background/History69
Corporate Structure70
Press Releases71
Products and Pipeline72
Therapeutic Focus72
Report Table of Contents
R&D status73
Products by Therapeutic Area74
Financials75
Beijing Double-crane Pharmaceutical Co., Ltd76
CoporateBackground76
Background/History76
Corporate structure76
Products and Pipeline77
Therapeutic Focus/Product77
IV solution products78
Financials83
Shanghai FosunPharmaceutical (group) Co. ltd.85
Corporate Background85
Background and History85
Corporate Structure86
Pharmaceutical division organization86
Press Releases87
Products and Pipeline90
Therapeutic and Industry focus90
Pharmaceuticals91
Medical Devices93
Diagnostics94
Medical Business/ distribution95
Products and Pipeline96
Financials97
Strategic direction for Pharma division102
SinovacBiotech Ltd.103
Corporate Background103
Background/History103
Corporate Structure104
Press Releases105
Products and Pipeline108
Therapeutic focus/ R&D strategy108
Products109
Brand111
Pipeline111
Financials112
3SBio, Ltd.118
Corporate Background118
Background/History118
Press Releases120
Products and Pipeline123
Therapeutic Focus123
Pipeline123
Products124
Brand125
Financials126
Growth strategies134
Shanghai Pharmaceutical (Group) Co., Ltd.135
Corporate Background135
Background/History135
Recent acquisitions136
Corporate Structure139
Press Releases140
Products143
Brand145
Financials146
Report Table of Contents
North China Pharmaceutical Group Corporation147
Corporate Background147
Background/History147
Corporate Structure and Brand147
Products and Pipeline148
Therapeutic Focus148
Products148
R&D149
Financials150
Yangtze River Pharmaceutical Group153
Corporate Background153
Background/History153
Corporate Structure and locations154
Products and Pipeline155
Therapeutic Focus155
Products156
Brand156
R&D157
China Resources Sanjiu Medical & Pharmaceutical Co. Ltd160
Corporate Background160
Background/History160
Corporate structure162
Products and Pipeline163
Therapeutic Focus163
Products164
Brand165
R&D165
Commercial infrastructure166
Financials167
Guangzhou Pharmaceutical Company169
Corporate Background169
Background/ History169
Corporate Structure171
Brand171
Products and Pipeline172
Therapeutic Focus172
Products and R&D172
Financials173
China Buchang Pharmaceutical Group176
Corporate Background176
Background/ History176
Corporate Structure178
Press Releases180
Products and Pipeline181
Therapeutic Focus181
Brand181
Products182
Finance183
Shandong Xinhua Pharmaceutical Co., Ltd.184
Corporate Background184
Background/ History184
Products and Pipeline186
Therapeutic Focus186
R&D186
Products187
Brand188
Financials189
Zhejiang Medicine Co., Ltd193
Corporate Background193
Background/ History193
Products and Pipelines195
Therapeutic Focus and products195
Export business organizational structure196
Brand198
Pipeline198
Financials199
American Oriental Bioengineering Inc.202
Corporate Background202
Background/ History202
Corporate structure204
Press Releases205
Products and Pipeline207
Therapeutic Focus207
Products207
R&D210
Brand210
Financials211
Growth strategy218